论文部分内容阅读
目的观察原发性肝癌选择性肝动脉栓塞化疗(TACE)术后近期的临床情况。方法回顾分析98例患者术后的不良反应及处理。结果 98例病员术后有85例发热,89例腹痛,29例恶心、呕吐,51例肝功损伤,1例肾功损伤,11例血细胞减少。结论 TACE治疗原发性肝癌具有创伤小、安全、并发症少、化疗副作用小、恢复快等特点,是治疗原发性肝癌中晚期安全有效的方法。
Objective To observe the short-term clinical conditions after selective hepatic artery embolization chemotherapy (TACE) for primary liver cancer. Methods Retrospective analysis of 98 patients with adverse reactions and treatment. Results There were 85 cases of fever, 89 cases of abdominal pain, 29 cases of nausea and vomiting, 51 cases of liver function impairment, 1 case of renal function impairment, and 11 cases of cytopenia after 98 cases. Conclusion TACE treatment of primary liver cancer is characterized by less trauma, safety, fewer complications, less side effects of chemotherapy, and rapid recovery. It is a safe and effective method for the treatment of primary liver cancer.